Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement genetic markers in schizophrenia: C3, BF and C6 polymorphisms.

L Fañanás1, P Moral, M A Panadero

  • 1Laboratory of Anthropology, Faculty of Biology, University of Barcelona, Spain.

Human Heredity
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophrenia.

Psychiatry research·2025
Same author

Theory of mind variability in schizophrenia: A neurodevelopmental perspective through neurological soft signs and premorbid adjustment.

Schizophrenia research. Cognition·2025
Same author

Lifetime suicidal thoughts, attempts, and lethality of attempts as major outcome domains of psychotic disorders: a 21-year prospective cohort study after a first-episode psychosis.

Psychological medicine·2025
Same author

Theory of mind in schizophrenia through a clinical liability approach: a sib-pair study.

Frontiers in psychology·2024
Same author

Effect of polygenic risk score, family load of schizophrenia and exposome risk score, and their interactions, on the long-term outcome of first-episode psychosis.

Psychological medicine·2023
Same author

Empirical validity of Leonhard's psychoses: A long-term follow-up study of first-episode psychosis patients.

Schizophrenia research·2023

Genetic variations in complement factors C3 and BF show associations with schizophrenia, though findings partially conflict with prior research. The study highlights statistical challenges in linking complement genetics to schizophrenia.

Area of Science:

  • Immunogenetics
  • Psychiatric Genetics
  • Molecular Psychiatry

Background:

  • Complement system factors (C3, BF, C6) are implicated in immune responses and have been studied in relation to schizophrenia.
  • Previous research presents conflicting results regarding the association between specific complement factor polymorphisms and schizophrenia.
  • Understanding these genetic links may offer insights into schizophrenia pathogenesis.

Purpose of the Study:

  • To investigate polymorphic variants of C3, BF, and C6 complement factors in patients with schizophrenia.
  • To analyze associations between these genetic variants and the presence of a family history of psychiatric disorders.
  • To reconcile conflicting findings in previous studies on complement genetics and schizophrenia.

Main Methods:

Related Experiment Videos

  • Genotyping of C3, BF, and C6 complement factor polymorphisms.
  • Patient stratification based on family history of schizophrenia and other psychiatric disorders.
  • Statistical analysis using log-linear models and contingency tables.
  • Main Results:

    • A significant decrease in C3*F variants was observed in schizophrenic patients, contradicting some previous findings.
    • A significant decrease in the FS phenotype of the BF system was found in patients, confirming some prior results.
    • No significant association was detected for C6 polymorphism with schizophrenia, aligning with previous studies.

    Conclusions:

    • The study provides partial confirmation of previous findings regarding complement factor associations with schizophrenia.
    • The observed decrease in C3*F variants warrants further investigation.
    • The results underscore the complexity and statistical challenges in establishing clear links between complement genetic markers and schizophrenia.